88 results
8-K
EX-10.2
ADAP
Adaptimmune Therapeutics Plc
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
Holder holding a Nominal-Cost Option ceases to be Connected for one of the following reasons:
death;
disability, injury or ill health (evidenced … and 13, if the Option Holder ceases to be Connected for any reason (including death);
if the Board shall have exercised its discretion pursuant to Rule
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
ceases to be Connected for one of the following reasons:
death;
disability, injury or ill health (evidenced to the satisfaction of the Board … 7.5, 7.6, 11 and 13, if the Option Holder ceases to be Connected for any reason (including death);
if the Board shall have exercised its discretion
424B3
mb5qgyzprw
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
9351o4gxppbl5ftv
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
8-K
EX-10.1
701307xc
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
S-4
kq0k4v yb0lq2cxb
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
424B5
inqinq5d7 qgq3g
28 Apr 22
Prospectus supplement for primary offering
8:09am